Reports for SANIS HEALTH INC
Company Name
SANIS HEALTH INC
Totals |
||
Shortage reports |
597 |
|
| Actual shortage: | 85 (14%) | |
| Anticipated shortage: | 2 (0%) | |
| Avoided shortage: | 16 (3%) | |
| Resolved: | 494 (83%) | |
Discontinuation Reports |
69 |
|
| To be discontinued: | 7 (10%) | |
| Discontinued: | 51 (74%) | |
| Reversed: | 11 (16%) | |
Late reports |
53 (8%) |
|
Overdue reports |
49 (52%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| CANDESARTAN | 16MG | TABLET | Resolved | 2024-01-17 | 2024-08-15 | 216273 |
| CANDESARTAN | 8MG | TABLET | Resolved | 2024-01-30 | 2024-04-23 | 217790 |
| CANDESARTAN | 4MG | TABLET | Resolved | 2023-07-18 | 2023-11-06 | 198936 |
| CANDESARTAN | 8MG | TABLET | Actual shortage | 2024-07-03 | 2024-07-04 | 232008 |
| CANDESARTAN | 8MG | TABLET | Resolved | 2020-02-27 | 2020-05-12 | 107299 |
| CANDESARTAN | 16MG | TABLET | Resolved | 2019-01-25 | 2019-02-26 | 73517 |
| CANDESARTAN | 8MG | TABLET | Actual shortage | 2024-08-01 | 2024-12-02 | 234192 |
| CANDESARTAN | 16MG | TABLET | Resolved | 2019-11-21 | 2020-05-28 | 99480 |
| CANDESARTAN | 4MG | TABLET | Resolved | 2023-11-22 | 2023-12-26 | 211086 |
| CANDESARTAN | 4MG | TABLET | Resolved | 2019-01-25 | 2019-05-16 | 73514 |
| CANDESARTAN | 32MG | TABLET | Resolved | 2019-10-21 | 2020-02-13 | 96884 |
| CANDESARTAN | 8MG | TABLET | Resolved | 2020-05-11 | 2020-10-21 | 114758 |
| CANDESARTAN | 32MG | TABLET | Resolved | 2019-01-25 | 2019-04-24 | 73520 |
| CANDESARTAN | 8MG | TABLET | Resolved | 2024-05-28 | 2024-07-16 | 228960 |
| CANDESARTAN | 32MG | TABLET | Resolved | 2018-09-04 | 2018-11-22 | 59777 |
| CANDESARTAN | 16MG | TABLET | Resolved | 2019-04-09 | 2019-05-16 | 80863 |
| CANDESARTAN | 4MG | TABLET | Resolved | 2018-09-07 | 2018-11-22 | 60200 |
| CANDESARTAN | 32MG | TABLET | Resolved | 2023-10-23 | 2024-03-11 | 207878 |
| CANDESARTAN | 32MG | TABLET | Resolved | 2020-03-26 | 2020-04-01 | 109439 |
| CANDESARTAN | 32MG | TABLET | Actual shortage | 2024-07-03 | 2024-12-02 | 232011 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| DILTIAZEM CD | Discontinued | 2020-02-27 | 2020-02-27 | 107342 | ||
| DILTIAZEM CD | Discontinued | 2020-02-27 | 2020-02-27 | 107353 | ||
| DILTIAZEM CD | Discontinued | 2020-02-27 | 2020-02-27 | 107357 | ||
| DILTIAZEM CD | 120MG | CAPSULE (CONTROLLED-DELIVERY) | Reversed | 2017-03-14 | 2017-07-31 | 2412 |
| DILTIAZEM CD | 180MG | CAPSULE (CONTROLLED-DELIVERY) | Reversed | 2017-03-14 | 2017-07-31 | 2416 |
| DILTIAZEM CD | 240MG | CAPSULE (CONTROLLED-DELIVERY) | Reversed | 2017-03-14 | 2017-07-31 | 2421 |
| DIVALPROEX | Discontinued | 2020-02-27 | 2020-02-27 | 107369 | ||
| DIVALPROEX | 125MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2389 |
| DIVALPROEX | 250MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2396 |
| DIVALPROEX | 500MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2402 |
| DIVALPROEX | Discontinued | 2020-02-27 | 2020-02-27 | 107375 | ||
| DIVALPROEX | Discontinued | 2020-02-27 | 2020-02-27 | 107372 | ||
| DULOXETINE | 60MG | CAPSULE (DELAYED RELEASE) | To be discontinued | 2024-02-15 | 2024-02-15 | 219591 |
| DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Reversed | 2024-02-15 | 2024-04-23 | 219618 |
| ETIDROCAL | 400MG 500MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4959 |
| FENOFIBRATE MICRO | 200MG | CAPSULE | Discontinued | 2017-08-02 | 2017-08-02 | 17972 |
| FENOFIBRATE-S | 100MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4891 |
| FENOFIBRATE-S | 160MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4894 |
| HYDROXYUREA | 500MG | CAPSULE | Discontinued | 2017-04-03 | 2017-04-03 | 5084 |
| INDAPAMIDE | 2.5MG | TABLET | Discontinued | 2017-03-14 | 2017-03-14 | 2450 |